natgillin/translations-raw huggingface dataset:
- Hjerneødem
- Double vision pain and inflammation of the eyes and eyelids, involuntary movement of the
- Dobbeltsyn, smerter og betændelsestilstand i øjne og øjenlåg, ufrivillige bevægelser i øjet
eye
- Nedsat berøringsfølelse
- Decreased sensitivity to touch
- Forstoppelse, betændelsestilstand i tyndtarmen, fordøjelsesbesvær, betændelse i bugspytkirtlen,
- Constipation, inflammation of upper small intestine, dyspepsia, pancreatitis, peritonitis
- Gummebetændelse
- Gingivitis,
- Hævelse og betændelsestilstand i tungen
- Swelling and inflammation of the tongue
- Forstørret lever, leverbetændelse, leversvigt, problemer med galdeblæren, galdesten
- Enlarged liver, hepatitis, liver failure, gallbladder disease, gallstones
- Betændelsestilstand i nyrerne, proteiner i urinen
- Inflammation of the kidney, proteins in the urine
- Unormalt elektrokardiogram (EKG)
- Abnormal electrocardiogram (ECG)
- Ændringer i blodbilledet
- Blood chemistry changes
Sjældne bivirkninger (det forekommer hos mellem 1 og 10 ud af 10. 000 patienter):
113 Rare side effects (occurring in at least 1 in 10,000 patients) are:
- Svært ved at sove
- Inability to sleep
- Problemer med hørelsen, ringen for ørerne
- Hearing difficulties, ringing in the ears
- Unormal smagsfornemmelse
- Abnormal sense of taste
- Øget spænding i musklerne, muskelsvaghed på grund af unormal reaktion i immunsystemet
- Increase in muscle tone, muscle weakness caused by an abnormal immune system
- Unormal hjernefunktion, Parkinson- lignende symptomer, kramper
- Abnormal brain function, Parkinson-like symptoms, convulsion
Da VFEND påvirker lever og nyrer, vil Deres læge tage blodprøver for at kontrollere lever - og nyrefunktionen.
As VFEND has been known to affect the liver and the kidney, your doctor should monitor the function of your liver and kidney by doing blood tests.
Hvis bivirkningerne fortsætter eller er generende, bedes De kontakte lægen.
If any of these side effects persist or are troublesome, please tell your doctor.
OPBEVARING
HOW TO STORE VFEND
Brug ikke VFEND efter den udløbsdato, der står på pakningen.
Do not use VFEND after the expiry date which is stated on the label.
Udløbsdatoen er den sidste i den nævnte måned.
The expiry date refers to the last day of the month.
Spørg på apoteket, hvordan De skal aflevere medicinrester.
Medicines should not be disposed of via wastewater or houshold waste.
VFEND indeholder:
FURTHER INFORMATION
Hver tablet indeholder enten 50 mg voriconazol (VFEND 50 mg
What VFEND contains  The active substance is voriconazole.
filmovertrukne tabletter) eller 200 mg voriconazol (VFEND 200 mg filmovertrukne tabletter).
Each tablet contains either 50 mg voriconazole (for VFEND 50 mg film-coated tablets) or 200 mg voriconazole (for VFEND 200 mg film-coated tablets).  The other ingredients are lactose monohydrate, pregelatinised starch, croscarmellose sodium, povidone and magnesium stearate which make up the tablet core and hypromellose, titanium dioxide (E171), lactose monohydrate and glycerol triacetate which make up the film-coat.
VFENDs udseende og pakningsstørrelse VFEND 50 mg filmovertrukne tabletter er hvide, runde filmovertrukne tabletter, som er præget med ” Pfizer ” på den ene side og VOR50 på den anden side.
What VFEND looks like and contents of the pack VFEND 50 mg film-coated tablets is supplied as white round film-coated tablets with Pfizer marked on one side and VOR50 on the reverse.
VFEND 200 mg filmovertrukne tabletter er hvide, kapselformede filmovertrukne tabletter, som er præget med ” Pfizer ” på den ene side og VOR200 på den anden side.
VFEND 200 mg film-coated tablets is supplied as white capsule shaped film-coated tablets with Pfizer marked on one side and VOR200 on the reverse.
Informationen i denne indlægsseddel omhandler udelukkende VFEND 50 mg tabletter og VFEND 200 mg tabletter.
The information in this leaflet is about VFEND 50 mg tablets and VFEND 200 mg tablets only.
For yderligere oplysninger om VFEND 200 mg pulver til infusionsvæske, opløsning eller VFEND 40 mg/ ml pulver til oral suspension, se venligst indlægssedlen for disse produkter.
For further information on VFEND 200 mg powder for solution for infusion or VFEND 40 mg/ ml powder for oral suspension, please see the User Package Leaflets for these products.
114 Indehaver af markedsføringstilladelsen Pfizer Limited, Ramsgate Road, Sandwich, Kent, CT13 9NJ, Storbritannien.
114 Marketing Authorisation Holder Pfizer Limited, Ramsgate Rd, Sandwich, Kent, CT13 9NJ, United Kingdom.
Fremstiller Pfizer Manufacturing Deutschland GmbH Heinrich- Mack- Str.
Manufacturer Pfizer Manufacturing Deutschland GmbH Heinrich-Mack-Str.
35 D- 89257 Illertissen Tyskland.
35 D-89257 Illertissen Germany
Hvis De vil have yderligere oplysninger om VFEND, skal De henvende Dem til den lokale repræsentant.
For any information about this medicinal product, please contact the local representative of the Marketing Authorisation Holder:
België / Belgique / Belgien Pfizer S. A. / N. V.
België / Belgique/ Belgien Pfizer S. A. / N. V.
Tél/ Tel: +32 (0) 2 554 62 11
Tél: +32 (0)2 554 62 11
България Пфайзер Люксембург САРЛ, Клон България тел.: +359 2 970 4333
България Пфайзер Люксембург САРЛ, Клон България Тел.: +359 2 970 4333
Simí: + 354 535 7000
115 Ísland Vistor hf., Sími: + 354 535 7000
Latvija Pfizer Luxembourg SARL, Filiāle Latvijā Tel: +371 670 35 775
Latvija Pfizer Luxembourg SARL Filiā le Latvijā Tel: +371 670 35 775
Lietuva Pfizer Luxembourg SARL Filialas Lietuvoje Tel.: +3705 2514000
Lietuva Pfizer Luxembourg SARL Filialas Lietuvoje Tel. +3705 2514000
De kan finde yderligere information om VFEND på Det europæiske Lægemiddelagenturs (EMEAs) hjemmeside http // www. emea. europa. eu /
Detailed information on this medicine is available on the European Medicines Agency (EMEA) web site: http: / /www. emea. europa. eu
116 INDLÆGSSEDDEL:
116 PACKAGE LEAFLET:
Spørg lægen eller på apoteket, hvis der er mere, De vil vide.
You may need to read it again.  If you have any questions, ask your doctor or pharmacist.  This medicine has been prescribed for you.
Det skal De vide, før De begynder at bruge VFEND 3.
Before you take VFEND 3.
Sådan bliver De behandlet med VFEND 4.
How to use VFEND 4.
VFEND bruges til behandling af alvorlige svampeinfektioner fremkaldt af Aspergillus, Scedosporium, Fusarium, fluconazol- resistente Candida og candidæmi hos de patienter, der har et normalt antal hvide blodlegemer.
VFEND is used to treat serious fungal infections caused by Aspergillus, Scedosporium, Fusarium, fluconazole-resistant Candida, and candidaemia in patients with normal white blood cell counts.
VFEND bruges for det meste hos alvorligt syge patienter.
VFEND is mainly for use in seriously ill patients.
DET SKAL DE VIDE, FØR DE BEGYNDER AT BRUGE VFEND
BEFORE YOU TAKE VFEND
De må ikke få VFEND
Do not take VFEND:
- hvis De er overfølsom (allergisk) over for det aktive stof voriconazol eller til sulfobutylether beta
- If you are allergic to the active ingredient voriconazole, or to sulphobutylether beta cyclodextrin
cyclodextrinnatrium.
sodium.
Følgende stoffer må ikke tages under behandlingen med VFEND:
However, the medicines in the following list must not be taken during your VFEND treatment:
117 • Rifampicin (medicin mod tuberkulose) • Carbamazepin (medicin mod epilepsi og kramper) • Phenobarbital (medicin mod alvorlig søvnløshed og krampeanfald) • Sekalealkaloider (f. eks. ergotamin, dihydroergotamin, medicin mod migræne) • Sirolimus (bruges til transplanterede patienter) • Ritonavir (medicin mod HIV) i doser på 400 mg og derover 2 gange dagligt • Perikon (urtemedicin)
 Terfenadine (used for allergy)  Astemizole (used for allergy)  Cisapride (used for stomach problems)  Pimozide (used for treating mental illness)  Quinidine (used for irregular heart beat)  Rifampicin (used for treating tuberculosis)  Carbamazepine (used to treat seizures) 117  Phenobarbital (used for severe insomnia and seizures)  Ergot alkaloids (e. g. ergotamine, dihydroergotamine; used for migraine)  Sirolimus (used in transplant patients)  Ritonavir (used for treating HIV) in doses of 400mg and more twice daily  St John’ s Wort (herbal supplement)
- hvis De ved, at De har problemer i hjertemuskulaturen (kardiomyopati), uregelmæssig puls,
Take special care with VFEND:  If you are known to have cardiomyopathy, irregular heart beat, slow heart rate or an abnormality of electrocardiogram (ECG) called ‘ long QT syndrome’.
Fortæl det til lægen, hvis De tager nogen af følgende former for medicin, da De ikke må tage VFEND, hvis De allerede tager et eller flere af disse lægemidler (se også afsnit 2 ” Tag ikke VFEND ”):
Tell your doctor if you are taking any of the following medicines, as VFEND must not be taken if you are already taking any of these medicines (See also Section 2 above ‘ Do not take VFEND):
• Terfenadin (medicin mod allergi) • Astemizol (medicin mod allergi) • Carbamazepin (medicin mod epilepsi og kramper) • Cisaprid (medicin mod maveproblemer) • Pimozid (medicin mod psykiske sygdomme) • Quinidin (medicin mod uregelmæssig puls) • Rifampicin (medicin mod tuberkulose) • Phenobarbital (medicin mod alvorlig søvnløshed og krampeanfald) • Sekalealkaloider (f. eks. ergotamin, dihydroergotamin, medicin mod migræne) • Sirolimus (bruges til transplanterede patienter) • Ritonavir (medicin mod HIV) i doser på 400 mg og derover 2 gange dagligt • Perikon (urtemedicin)
 Terfenadine (used for allergy)  Astemizole (used for allergy)  Carbamazepine (used to treat seizures)  Cisapride (used for stomach problems)  Pimozide (used for treating mental illness)  Quinidine (used for irregular heart beat)  Rifampicin (used for treating tuberculosis)  Phenobarbital (used for severe insomnia and seizures)  Ergot alkaloids (e. g. ergotamine, dihydroergotamine; used for migraine)  Sirolimus (used in transplant patients)  Ritonavir (used for treating HIV) in doses of 400 mg and more twice daily  St John’ s Wort (herbal supplement)
Fortæl det til lægen, hvis De tager følgende medicin, da behandling samtidig med VFEND bør undgås, hvis det er muligt: • Ritonavir (medicin mod HIV) i doser på 100 mg 2 gange dagligt
Tell your doctor if you are taking the following medicine, as treatment with VFEND at the same time should be avoided if possible:  Ritonavir (used for treating HIV) in doses of 100 mg twice daily
Det kan være nødvendigt at justere voriconazoldosis: • Rifabutin (medicin mod tuberkulose) • Phenytoin (medicin mod epilepsi)
Tell your doctor if you are taking either of the following medicines, as treatment with VFEND at the same time should be avoided if possible, and a dose adjustment of voriconazole may be required:  Rifabutin (used for treating tuberculosis)  Phenytoin (used to treat epilepsy)
Fortæl det til lægen, hvis De tager følgende medicin, da det kan være nødvendigt at justere dosis og kontrollere, om medicinen og/ eller VFEND stadig har den ønskede virkning: • Warfarin og anden blodfortyndende medicin( f. eks. phenprocoumon, acenocoumarol; bruges til at nedsætte blodets evne til at størkne) • Ciclosporin (bruges til transplanterede patienter) • Tacrolimus (bruges til transplanterede patienter) • Sulfonylurinstoffer (f. eks. tolbutamid, glipizid og glyburid) (medicin mod diabetes) • Statiner (f. eks. atorvastatin, simvastatin) (kolesterolsænkende medicin) • Benzodiazepiner (f. eks. midazolam, triazolam) (medicin mod alvorlig søvnløshed og stress) • Omeprazol (medicin mod mavesår)
Tell your doctor if you are taking any of the following medicines, as a dose adjustment or monitoring may be required to check that the medicines and/ or VFEND are still having the desired effect:  Warfarin and other anticoagulants (e. g. phenprocoumon, acenocoumarol; used to slow down clotting of the blood)  Ciclosporin (used in transplant patients)  Tacrolimus (used in transplant patients)  Sulphonylureas (e. g. tolbutamide, glipizide, and glyburide) (used for diabetes)  Statins (e. g. atorvastatin, simvastatin) (used for lowering cholesterol)  Benzodiazepines (e. g midazolam, triazolam) (used for severe insomnia and stress)  Omeprazole (used for treating ulcers)  Oral contraceptives (if you take VFEND whilst using oral contraceptives, you may get side effects such as nausea and menstrual disorders)  Vinca alkaloids (e. g. vincristine and vinblastine) (used in treating cancer)  Indinavir and other HIV protease inhibitors (used for treating HIV)
118 • Oral svangerskabsforebyggende medicin (hvis De tager VFEND sammen med oral svangerskabsforebyggende medicin, kan De få bivirkninger, såsom kvalme og menstruationsforstyrrelser) • Vinkaalkaloider (f. eks. vincristin og vinblastin) (medicin mod cancer) • Indinavir og andre HIV- proteasehæmmere (medicin mod HIV) • Non- nucleosid reverse transcriptase- hæmmere (f. eks. efavirenz, delavirdin, nevirapin) (medicin mod HIV) • Methadon (medicin mod heroinmisbrug) • Efavirenz (medicin mod HIV) (nogle doser af efavirenz kan IKKE tages på samme tid som VFEND) • Alfentanil og andre korttidsvirkende opiater, såsom fentanyl og sufentanil (smertestillende medicin, der bruges ved operationer) • Nonsteroid antiinflammatorisk medicin (f. eks. ibuprofen, diclofenac) (medicin mod smerter og betændelsestilstande)
118  Non-nucleoside reverse transcriptase inhibitors (e. g. efavirenz, delavirdine, nevirapine) (used for treating HIV)  Methadone (used to treat heroin addiction)  Efavirenz (used for treating HIV) (some doses of efavirenz can NOT be taken at the same time as VFEND)  Alfentanil and other short acting opiates such as fentanyl and sufentanil (painkillers used for surgical procedures)  Non-steroidal anti-inflammatory drugs (e. g. ibuprofen, diclofenac) (used for treating pain and inflammation)
Før De behandles med VFEND, bør De fortælle Deres læge om
Before being treated with VFEND, tell your doctor if:  you have had an allergic reaction to other azoles.  you are suffering from, or have ever suffered from kidney disease.
Afhængig af hvor alvorlig nyresygdommen er, kan Deres læge beslutte at give Dem VFEND tabletter.
Dependent upon the degree of kidney disease the doctor may decide to give you VFEND tablets.
Deres læge vil kontrollere Deres nyrefunktion under behandling med VFEND ved at tage blodprøver.
Your doctor should monitor your renal function while you are being treated with VFEND by doing blood tests.  you are suffering from, or have ever suffered from liver disease.
− De allerede behandles med phenytoin (medicin mod epilepsi).
Your doctor should also monitor your liver function while you are being treated with VFEND by doing blood tests.  you are already being treated with phenytoin (used to treat epilepsy).
Koncentrationen af phenytoin i Deres blod skal kontrolleres under behandlingen med VFEND, og Deres dosis skal muligvis justeres.
Your blood concentration of phenytoin will need to be monitored during your treatment with VFEND and your dose may be adjusted.  you are already being treated with rifabutin (used for treating tuberculosis).
Det er nødvendigt at kontrollere Deres blodtal og følge rifabutins bivirkninger.
Your blood counts and side effects to rifabutin will need to be monitored.
− Fortæl straks Deres læge, hvis De får alvorligt hududslæt eller blærer.
While being treated with VFEND:  tell your doctor immediately if you develop a severe skin rash or blisters.  avoid sunlight while being treated with VFEND, as an increased sensitivity of skin to the sun’ s UV rays can occur.  your doctor should monitor the function of your liver and kidney by doing blood tests.  reactions during the infusion have occurred uncommonly with VFEND (including flushing and nausea).
− Deres læge skal tage blodprøver til bestemmelse af Deres lever - og nyrefunktion.
Your doctor may stop the infusion of VFEND if this occurs.
Lægen vil muligvis afbryde behandlingen med VFEND, hvis disse reaktioner opstår.
Pregnancy and breast-feeding:
Graviditet og amning De må ikke tage VFEND under graviditet, medmindre det er foreskrevet af Deres læge.
VFEND must not be used during pregnancy, unless indicated by your doctor.
Hvis De ammer, må De ikke tage VFEND.
VFEND must not be used during breast-feeding.
Spørg Deres læge eller apotek til råds, inden De tager nogen form for medicin, mens De ammer.
Ask your doctor or pharmacist for advice before taking any medicine whilst breast-feeding.
119 Trafik - og arbejdssikkerhed VFEND kan forårsage sløring af synet eller ubehagelig lysfølsomhed.
VFEND may cause blurring of vision or uncomfortable sensitivity to light.
Vigtig information om nogle af de øvrige indholdsstoffer i VFEND Hvert hætteglas indeholder 217, 6 mg natrium.
Important information about some of the ingredients of VFEND Each vial of VFEND contains 217.6 mg of sodium per vial.
Dette skal De tage hensyn til, hvis De er på natrium - eller saltfattig diæt.
This should be taken into consideration if you are on a strictly controlled sodium diet.
Tag altid VFEND nøjagtigt efter lægens anvisning.
HOW TO USE VFEND Always take VFEND exactly as your doctor has told you.
Er De i tvivl så spørg lægen eller på apoteket.
You should check with your doctor if you are not sure.
Deres læge kan ændre Deres dosis afhængig af Deres tilstand.
Your doctor will determine your dose depending on your weight and the type of infection you have.
• Den sædvanlige dosis for voksne (også ældre) er:
119 The usual dose for adults (including elderly patients) is as follows:
Dosis i de første 24 timer (Initialdosis)
Intravenous 6 mg/ kg every 12 hours for Dose for the first 24 hours the (Loading Dose)
6 mg/ kg hver 12. time i de første 24 timer
first 24 hours
Dosis efter de første 24 timer (Vedligeholdelsesdosis)
Dose after the first 24 hours 4 mg/ kg twice a day (Maintenance Dose)
Afhængig af behandlingens virkning, vil lægen måske øge den daglige dosis til 300 mg 2 gange dagligt.
Depending on your response to treatment, your doctor may decrease the dose to 3 mg/ kg twice daily.
• Den sædvanlige dosis til børn i alderen fra 2 år til under 12 år er 7 mg/ kg 2 gange dagligt. • Den sædvanlige dosis til unge (12- 16 år) er den samme, som til voksne.
 The usual dose for children aged 2 to less than 12 years is 7 mg/ kg twice daily.
VFEND bør ikke bruges til børn under 2 år.
 The usual dose for teenagers (aged 12 to 16 years) is the same as for adults..
(Se bagest i indlægssedlen for yderligere oplysninger).
(Please refer to the end of this leaflet for further information)
VFEND vil blive indgivet over 1- 2 timer som intravenøs infusion (ind i en vene) med en maksimal infusionshastighed på 3 mg/ kg/ time.
This will be given to you by intravenous infusion (into a vein) at a maximum rate of 3 mg/ kg per hour over 1 to 2 hours.
De må højst behandles med VFEND pulver til infusionsvæske, opløsning i 6 måneder.
VFEND treatment will continue for as long as your doctor advises, however duration of treatment with VFEND powder for solution for infusion should be no more than 6 months.
120 Hvis en dosis af VFEND er blevet glemt Da De vil få denne medicin under tæt medicinsk overvågning, er det mindre sandsynligt, at en dosis vil blive glemt.
As you will be given this medicine under close medical supervision, it is unlikely that a dose would be missed.
Hvis De holder op med at bruge VFEND Når Deres læge stopper VFEND- behandlingen, bør De ikke kunne mærke det.
When VFEND treatment is stopped by your doctor you should not experience any effects.
Spørg lægen, hvis der er noget, De er i tvivl om, eller føler Dem usikker på.
If you have any further questions on the use of this product, ask your doctor.
VFEND kan som al anden medicin give bivirkninger, men ikke alle får bivirkninger.
POSSIBLE SIDE EFFECTS Like all medicines, VFEND can cause side effects, although not everybody gets them.
Meget almindelige bivirkninger (det forekommer hos flere end 1 ud af 10 patienter):
120 Very common side effects (occurring in at least 1 in 10 patients) are:
- Synsforstyrrelser (ændring i synet)
-Visual disturbances (change in vision) -Fever -Rash -Nausea, vomiting, diarrhoea -Headache -Swelling of the extremities -Stomach pains.
lavt antal af visse typer hvide blodlegemer eller alle typer blodlegemer, rødfarvning eller violetfarvning af huden, som skyldes lavt trombocyttal eller forandringer i blodet
-Flu-like symptoms, sinusitis, chills, weakness -Anaemia, low numbers of cells called platelets that help the blood to clot, low numbers of some types of white blood cells or of all types of blood cells, red or purple discoloration of the skin which may be caused by low platelet count, other blood cell changes -Low blood sugar, low blood potassium -Anxiety, depression, tingling, confusion, dizziness, agitation, trembling, hallucinations and other nervous symptoms -Low blood pressure, inflammation of a vein (which may be associated with the formation of a blood clot) -Breathing difficulty, chest pain, fluid accumulation in the lungs -Jaundice, redness of the skin -Swelling of the lips or face -Allergic reactions (sometimes severe), including widespread blistering rash and skin peeling, severe skin reaction following exposure to light or sun -Itchiness -Hair loss -Back pain -Kidney failure, blood in the urine, changes in blood tests of kidney function -Inflammation at injection sites -Changes in blood tests of liver function
- Overfølsomhedsreaktioner (undertiden alvorlig), herunder udbredt blæredannelse, hududslæt og
Uncommon side effects (occurring in at least 1 in 1,000 patients) are:
afskalning af huden, alvorlige hudreaktioner på grund af lys eller solens stråler
-Enlarged lymph glands (sometimes painful) -Increase in a type of white blood cell which may be associated with allergic reaction, disorder of blood clotting system -Heart rhythm problems including very fast heartbeat, very slow heartbeat, fainting -Depressed function of the adrenal gland -Problem with coordination -Swelling of the brain -Double vision pain and inflammation of the eyes and eyelids, involuntary movement of the eye -Decreased sensitivity to touch -Constipation, inflammation of upper small intestine, dyspepsia, pancreatitis, peritonitis -Gingivitis, -Swelling and inflammation of the tongue -Enlarged liver, hepatitis, liver failure, gallbladder disease, gallstones -Joint pain -Inflammation of the kidney, proteins in the urine -Abnormal electrocardiogram (ECG) -Blood chemistry changes
- Forstørrede lymfeknuder (undertiden smertefuldt)
Rare side effects (occurring in at least 1 in 10,000 patients) are:
- Koordinationsproblemer
- Inability to sleep
- Dobbeltsyn, smerter og betændelsestilstand i øjne og øjenlåg, ufrivillige bevægelser i øjet
-Hearing difficulties, ringing in the ears -Abnormal sense of taste
121
121 -Increase in muscle tone, muscle weakness caused by an abnormal immune system response -Abnormal brain function, Parkinson-like symptoms, convulsion -Sleepiness during infusion
Tal med lægen eller apoteket, hvis en bivirkning bliver værre, eller hvis De får bivirkninger, som ikke er nævnt her.
If any of the side effects gets serious or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.
Opbevares utilgængeligt for børn.
Keep VFEND out of the reach and sight of children.
VFEND skal bruges umiddelbart efter rekonstitution, men hvis nødvendigt kan den rekonstituerede opløsning opbevares op til 24 timer ved 2°C til 8°C (i køleskab).
Once reconstituted, VFEND should be used immediately, but if necessary may be stored for up to 24 hours at 2°C - 8°C (in a refrigerator).
VFEND indeholder:
What VFEND contains
− Ativt stof: voriconazol. − Øvrigt indholdsstof: sulfobutylether beta cyclodextrinnatrium.
-The active substance is voriconazole. -The other ingredient is sulphobutylether beta cyclodextrin sodium.
122 Hvert hætteglas indeholder 200 mg voriconazol svarende til 10 mg/ ml opløsning efter rekonstitution, som foreskrevet af sygehusapoteket eller sygeplejersken (se bagest i indlægssedlen for yderligere oplysninger).
Each vial contains 200 mg voriconazole, equivalent to a 10 mg/ ml solution when reconstituted as directed by your hospital pharmacist or nurse (see the information at the end of this leaflet).
VFENDs udseende og pakningsstørrelse VFEND findes i hætteglas af glas som pulver til infusionsvæske, opløsning beregnet til engangsbrug.
What VFEND looks like and contents of the pack